Riik: Suurbritannia
keel: inglise
Allikas: MHRA (Medicines & Healthcare Products Regulatory Agency)
Simvastatin
PLIVA Pharma Ltd
C10AA01
Simvastatin
40mg
Oral tablet
Oral
No Controlled Drug Status
Valid as a prescribable product
BNF: 02120000
PACKAGE LEAFLET: INFORMATION FOR THE USER SIMVASTATIN 10MG TABLETS SIMVASTATIN 20MG TABLETS SIMVASTATIN 40MG TABLETS (simvastatin) READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor or pharmacist. - This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours. - If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor. IN THIS LEAFLET: 1. What Simvastatin Tablets are and what they are used for 2. Before you take Simvastatin Tablets 3. How to take Simvastatin Tablets 4. Possible side effects 5. How to store Simvastatin Tablets 6. Further information 1. WHAT SIMVASTATIN TABLETS ARE AND WHAT THEY ARE USED FOR Simvastatin belongs to a group of medicines called ‘HMG-CoA reductase inhibitors’ which reduce the amount of cholesterol and fatty substances called triglycerides in the blood. Cholesterol is vital to the normal functioning of the body but if levels in the bloodstream are too high, it can be deposited on the walls of the arteries and build up to form plaques which can eventually block the blood vessel. Simvastatin Tablets are used to: lower levels of cholesterol (and triglycerides) in the blood, thereby reducing the risk of heart disease slow or reduce the progression of : o atherosclerosis (clogging of blood vessels by cholesterol) which can lead to angina (chest pain) and heart attack. o coronary heart disease (CHD) - Simvastatin Tablets can help to lessen the risk of a heart attack. 2. BEFORE YOU TAKE SIMVASTATIN TABLETS DO NOT TAKE SIMVASTATIN TABLETS if you: are allergic (hypersensitive) to simvastatin or any of the other ingredients in the product (_see_ _Section 6 and end of section 2)_ have liver problems or continual raised transaminase levels (liver enzymes) in your blood are taking any of the following medicines: itraconazole, ke Lugege kogu dokumenti
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Simvastatin 40mg Tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 40mg simvastatin For excipients see 6.1 3 PHARMACEUTICAL FORM Film-coated tablet White, oblong, biconvex, film-coated tablets scored on one side and embossed with ‘40’ on scored side and with ‘SVT’ on the opposite side. Or White, oblong, biconvex film-coated tablets scored on both sides embossed with ’SVT’ and ‘40’ on one side. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Hypercholesterolaemia Treatment of primary hypercholesterolaemia or mixed dyslipidaemia, as an adjunct to diet, when response to diet and other non-pharmacological treatments (e.g. exercise, weight reduction) is inadequate. Treatment of homozygous familial hypercholesterolaemia as an adjunct to diet and other lipid lowering treatments (e.g. LDL apheresis) or if such treatments are not appropriate. Cardiovascular prevention Reduction of cardiovascular mortality and morbidity in patients with manifest atherosclerotic cardiovascular disease or diabetes mellitus, with either normal or increased cholesterol levels, as an adjunct to correction of other risk factors and other cardioprotective therapy (see section 5.1) 4.2 POSOLOGY AND METHOD OF ADMINISTRATION The dosage range is 5-80 mg/day given orally as a single dose in the evening. Adjustments of dosage, if required, should be made at intervals of not less than 4 weeks, to a maximum of 80mg/day given as a single dose in the evening. The 80mg dose is only recommended in patients with severe hypercholesterolaemia and high risk for cardiovascular complications. Hypercholesterolaemia The patient should be placed on a standard cholesterol-lowering diet, and should continue on this diet during treatment with Simvastatin. The usual starting dose is 10-20 mg/day given as a single dose in the evening. Patients who require a large reduction in LDL-C (more than 45%) may be started at 20- 40 mg/day given as a single dose in the evening Lugege kogu dokumenti